Back
Oruka Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
ORKA
Oruka Therapeutics, Inc.
Last Price:
$39.93
Seasonality Move:
-0.42%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight selling pressure.
Oruka Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.68 | Buy |
| 20-day SMA: | 33.45 | Buy |
| 50-day SMA: | 32.54 | Buy |
| 200-day SMA: | 22.83 | Buy |
| 8-day EMA: | 21.44 | Buy |
| 20-day EMA: | 11.13 | Buy |
| 50-day EMA: | 4.98 | Buy |
| 200-day EMA: | 1.32 | Buy |
Oruka Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.52 | Buy |
| Relative Strength Index (14 RSI): | 55.04 | Buy |
| Chaikin Money Flow: | -149232 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.29 - 34.33) | Buy |
| Bollinger Bands (100): | (27.9 - 33.46) | Buy |
Oruka Therapeutics, Inc. Technical Analysis
| Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 9 | Mar 10 | Mar 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oruka Therapeutics, Inc. Stock
Is Oruka Therapeutics, Inc. Stock a Buy?
-
Oruka Therapeutics, Inc. share price is 34.41 while ORKA 8-day simple moving average is 33.68, which is a Buy signal.
-
The stock price of ORKA is 34.41 while Oruka Therapeutics, Inc. 20-day SMA is 33.45, which makes it a Buy.
-
Oruka Therapeutics, Inc. 50-day simple moving average is 32.54 while ORKA share price is 34.41, making it a Buy technically.
-
ORKA stock price is 34.41 and Oruka Therapeutics, Inc. 200-day simple moving average is 22.83, creating a Buy signal.
ORKA Technical Analysis vs Fundamental Analysis
Buy
59
Oruka Therapeutics, Inc. (ORKA)
is a Buy
Is Oruka Therapeutics, Inc. a Buy or a Sell?
-
Oruka Therapeutics, Inc. stock is rated a BuyThe current Oruka Therapeutics, Inc. [ORKA] share price is $34.41. The Score for ORKA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Oruka Therapeutics, Inc. Stock Info
Market Cap:
1.9B
Price in USD:
34.41
Share Volume:
503K
Oruka Therapeutics, Inc. 52-Week Range
52-Week High:
41.19
52-Week Low:
5.49
Buy
59
Oruka Therapeutics, Inc. (ORKA)
is a Buy
Oruka Therapeutics, Inc. Share Price Forecast
-
What is the Oruka Therapeutics, Inc. stock price today?The Oruka Therapeutics, Inc. stock price is 34.41 USD today.
-
Will ORKA stock go up or go down?Oruka Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Oruka Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oruka Therapeutics, Inc. is not overvalued.
Is Oruka Therapeutics, Inc. Stock a Buy?
-
Oruka Therapeutics, Inc. share price is 34.41 while ORKA 8-day exponential moving average is 21.44, which is a Buy signal.
-
The stock price of ORKA is 34.41 while Oruka Therapeutics, Inc. 20-day EMA is 11.13, which makes it a Buy.
-
Oruka Therapeutics, Inc. 50-day exponential moving average is 4.98 while ORKA share price is 34.41, making it a Buy technically.
-
ORKA stock price is 34.41 and Oruka Therapeutics, Inc. 200-day simple moving average is 1.32, creating a Buy signal.
Fundamental Analysis of Oruka Therapeutics, Inc.
Is Oruka Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.44 per share.
Technical Analysis of Oruka Therapeutics, Inc.
Should I short Oruka Therapeutics, Inc. stock?
-
ORKA Moving Average Covergence Divergence (MACD) indicator is 7.52, suggesting Oruka Therapeutics, Inc. is a Buy
-
Oruka Therapeutics, Inc. Relative Strength Index (RSI) is 55.04, which suggest Oruka Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Oruka Therapeutics, Inc. is (32.29 - 34.33), which suggest Oruka Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Oruka Therapeutics, Inc. is (27.9 - 33.46), which suggest Oruka Therapeutics, Inc. is a Buy
* Oruka Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.